Clinical Trials
10 trialsNCT07286318 2026-04-02
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
Phase EARLY_PHASE1 Not yet recruiting
NCT04480645 2026-03-24
CivaDerm(TM) Surface Therapy Pilot Study
CivaTech Oncology
Phase EARLY_PHASE1 Completed
NCT07144384 2026-02-13
Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT04279535 2021-11-02
Topical Vitamin C for Treatment of Basal Cell Cancer
Center for Biomedical Research, Inc.
Phase EARLY_PHASE1 Completed
NCT02120677 2020-12-16
Topical Itraconazole in the Treatment of Basal Cell Carcinoma
Johns Hopkins University
Phase EARLY_PHASE1 Completed
NCT02699723 2020-10-22
Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer
Stanford University
Phase EARLY_PHASE1 Withdrawn
NCT04570683 2020-09-30
Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas
Bispebjerg Hospital
Phase EARLY_PHASE1 Unknown
NCT02735356 2019-04-11
Topical Itraconazole in Treating Patients With Basal Cell Cancer
Stanford University
Phase EARLY_PHASE1 Completed
NCT01631331 2017-12-08
Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)
Stanford University
Phase EARLY_PHASE1 Completed
NCT00663910 2017-01-02
Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer
The Cleveland Clinic
Phase EARLY_PHASE1 Terminated